HERBALIFE LTD
HLFNYSE🏆 #2185 by market capEarnings Nov 4US Equity
$11.77▲ $0.02 (+0.21%)
Live1h▲ 0.0%
24h▲ 0.2%
7d▼ 6.6%
14d▼ 5.9%
30d▼ 10.2%
1y▲ 28.3%
🏦Market Cap
$1.22B
Small Cap
📈Revenue Growth (YoY)
+5.5%
Slowing
📊Gross Margin
77.7%
High
💵FCF Margin
6.2%
Moderate
⚖️P/S Ratio
0.2x
Cheap
Otter Score
42
Weak
📊
Analyst Ratings
Price
$11.77
Total
26
Raised
6
Lowered
7
Avg PT
$17.00
H / L
$17 / $17
| Institution | Action | Rating | Date |
|---|---|---|---|
RBC Capital | Reiterated | Sector Perform | 2026-04-28 |
Mizuho | Reiterated | Neutral | 2026-03-30 |
Citigroup | Reiterated | Buy | 2026-02-19 |
Argus Research | Upgraded | Hold → Buy | 2025-11-26 |
DA Davidson | Upgraded | Neutral → Buy | 2025-03-21 |
B. Riley Securities | Reiterated | Buy | 2024-10-31 |
B of A Securities | Reiterated | Underperform | 2024-03-21 |
Jefferies | Upgraded | Hold → Buy | 2022-07-12 |
Citi | Reiterated | Buy | 2019-08-02 |
Argus | Downgraded | Buy → Hold | 2018-05-05 |
Tigress Financial | Reiterated | Buy | 2017-04-24 |
Pivotal Research | Reiterated | Buy | 2015-08-27 |
Canaccord Genuity | Reiterated | Buy | 2015-05-06 |
Barclays | Reiterated | Overweight | 2015-01-15 |
Buckingham Research | Downgraded | Buy → Neutral | 2015-01-05 |
BTIG Research | Reiterated | Buy | 2014-11-19 |
SunTrust Robinson Humphrey | Downgraded | Buy → Neutral | 2014-11-03 |
Argus Capital | Downgraded | Buy → Hold | 2014-03-21 |
S&P Capital IQ | Upgraded | Sell → Hold | 2014-01-23 |
Wedbush | Reiterated | Outperform | 2013-12-27 |
Makor Capital | Downgraded | Buy → Hold | 2013-07-24 |
D.A. Davidson | Upgraded | Neutral → Buy | 2013-04-12 |
Janney Capital | Downgraded | Buy → Neutral | 2013-01-11 |
Janney Montgomery Scott | Downgraded | Buy → Neutral | 2013-01-11 |
Caris & Co. | Upgraded | Average → Buy | 2012-05-17 |
Auriga | Reiterated | Hold | 2012-02-23 |
One row per institution, most recent rating